The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, ...

By Maggie Fick LONDON, Feb 5 (Reuters) - Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday ...

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisk's (NVO) Wegovy pill.

Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk, prompting the drugmaker to accuse the telehealth platform of “illegal mass ...

Q4 2025 Earnings Call February 5, 2026 8:15 AM ESTCompany ParticipantsMaziar Doustdar - President, CEO & Member of ...

Shortly after reporting weaker-than-expected sales of its injectable GLP-1 drugs, Novo Nordisk revealed clinical results with an oral alternative that suggest it can offer comparable efficacy with ...

Not even two days after Novo Nordisk A/S pinned its comeback hopes on a new weight-loss pill that’s off to a strong start, a knock-off version is already on the market that the Danish drugmaker says ...

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much ...

Between 2012 and 2015, the number of chemical burns to the eye associated with laundry detergent pods increased more than 30-fold among preschool-aged children in the US, according to a study. Between ...

Danish pharmaceutical company Novo Nordisk A/S has raised 4 billion euros ($4.7 billion) through the sale of bonds to finance the acquisition of American biotech company Akero Therapeutics Inc. This ...

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, ...